Delivery Order SPE2DB22D1002-SPE2DB24FLHB0
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,568.50 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including critical care...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,305.05 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This delivery order contract, valued at $8,569.49, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of September 23, 2024 and is structured as a firm fixed price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $6,284.63 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with an ultimate completion date of August 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The delivery order has a ceiling value of $23,398.17 and a firm fixed price pricing type. The contract does not have a set-aside designation and is...
This is a $10,784.33 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML and has an ultimate completion date of April 29, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,361.45 firm-fixed-price contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a performance period through July 2, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,616.78 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The award, which has no set-aside designation, has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to various federal agencies and healthcare programs, including the military....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $6,318.04 firm fixed-price contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a final completion date of September 16, 2024. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract with DLA Troop Support Medical, valued up to...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,762.96 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...